journal article·2025-07-11

Multifunctional Carbon Nanospheres Induced Immunogenic Cell Death and Inhibited Distal Tumor Growth Based on the Synergistic Effect of Chemodynamic Therapy/Photothermal Therapy

Siqi Li, Xu Zhu, Yujun Bao, Guanghao Li, Ziqing Yang, Mingyue Ma, Zhiqiang Wang, Rui Yan, Xiaodan Wu, Guanghui Tan, Yingxue Jin

ACS Applied Nano Materials· Volume 8· Issue 27
Publisher page

Abstract

Although immune checkpoint blocking therapy (ICB) has great application prospects, it is limited by the insufficient immunogenicity of the tumor microenvironment (TME). Photothermal therapy (PTT) and chemodynamic therapy (CDT) can increase the immunocompetence of the TME by inducing immunogenic cell death (ICD). This study, based on the strategy of CDT–PTT synergistically enhancing ICD and combining with ICB, synthesized a nanomedicine delivery system (Cu-TFCNS) with CDT–PTT–ICD functions in one step using a simple “bottom-up” solvothermal method. Cu-TFCNS can actively target tumor cells. Under the stimulation of near-infrared light and the TME, the effect induces a strong ICD. In vitro and in vivo experiments have shown that the combination of Cu-TFCNS and anti PD-L1 body can effectively inhibit the growth of primary tumors and distant metastases (Scheme 1). This study provides an effective ICB strategy to promote antitumor immunotherapy and a method for simple preparation of multifunctional carbon-based nanoimmune adjuvants.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering

Harbin Normal University

Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology

Shandong University School of Basic Medical Sciences

Funding

Joint Foundation of Natural Science Foundation Heilongjiang Province of China · Graduate Innovation Projects of Harbin Normal University · Key Projects of Natural Science Foundation of Heilongjiang Province of China

References (65)

Show source-provided references
1. 10.1186/s12943-023-01770-610.1186/s12943-023-01770-6 ↗
2. 10.3390/ijms2207341810.3390/ijms22073418 ↗
3. 10.6004/jnccn.2020.001610.6004/jnccn.2020.0016 ↗
4. 10.1002/advs.20230028610.1002/advs.202300286 ↗
5. 10.1016/j.bioactmat.2023.05.01610.1016/j.bioactmat.2023.05.016 ↗
6. 10.20517/cdr.2023.6010.20517/cdr.2023.60 ↗
7. 10.1186/s12916-021-02213-z10.1186/s12916-021-02213-z ↗
8. 10.1038/nature1067310.1038/nature10673 ↗
9. 10.1002/1878-0261.1285110.1002/1878-0261.12851 ↗
10. 10.1021/acsnano.4c0122910.1021/acsnano.4c01229 ↗
11. 10.3390/pharmaceutics1308115110.3390/pharmaceutics13081151 ↗
12. 10.3109/1061186X.2015.105104910.3109/1061186X.2015.1051049 ↗
13. 10.1080/1061186X.2023.220560910.1080/1061186X.2023.2205609 ↗
14. 10.1002/smll.20210386810.1002/smll.202103868 ↗
15. 10.2217/nnm-2022-018710.2217/nnm-2022-0187 ↗
16. 10.3390/pharmaceutics1309133210.3390/pharmaceutics13091332 ↗
17. 10.1021/acs.accounts.0c0060610.1021/acs.accounts.0c00606 ↗
18. 10.1016/j.jconrel.2020.06.03210.1016/j.jconrel.2020.06.032 ↗
19. 10.1016/j.jcis.2024.04.15110.1016/j.jcis.2024.04.151 ↗
20. 10.2217/nnm-2022-018710.2217/nnm-2022-0187 ↗
21. 10.1016/j.biomaterials.2020.12047410.1016/j.biomaterials.2020.120474 ↗
22. 10.1021/acsanm.4c0445710.1021/acsanm.4c04457 ↗
23. 10.1002/advs.20220173410.1002/advs.202201734 ↗
24. 10.1002/adfm.20221140210.1002/adfm.202211402 ↗
25. 10.1038/cddis.2013.15610.1038/cddis.2013.156 ↗
26. 10.1038/s41420-024-02121-010.1038/s41420-024-02121-0 ↗
27. 10.1186/s12885-020-06964-510.1186/s12885-020-06964-5 ↗
28. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
29. 10.2147/DDDT.S44749610.2147/DDDT.S447496 ↗
30. 10.1002/mco2.76710.1002/mco2.767 ↗
31. 10.1016/j.ccr.2024.21571810.1016/j.ccr.2024.215718 ↗
32. 10.1021/acs.accounts.4c0003110.1021/acs.accounts.4c00031 ↗
33. 10.1016/j.apsb.2021.08.01210.1016/j.apsb.2021.08.012 ↗
34. 10.3390/nano1212202210.3390/nano12122022 ↗
35. 10.3390/pharmaceutics1411246310.3390/pharmaceutics14112463 ↗
36. 10.1021/acsnano.2c0012810.1021/acsnano.2c00128 ↗
37. 10.1002/smll.20200709010.1002/smll.202007090 ↗
38. 10.1016/j.actbio.2022.06.00110.1016/j.actbio.2022.06.001 ↗
39. 10.1039/D1SC07073H10.1039/D1SC07073H ↗
40. 10.1039/D4SC05280C10.1039/D4SC05280C ↗
41. 10.1021/acs.nanolett.4c0341810.1021/acs.nanolett.4c03418 ↗
42. 10.1021/acs.chemrev.6b0075510.1021/acs.chemrev.6b00755 ↗
43. 10.1021/acsami.4c0085310.1021/acsami.4c00853 ↗
44. 10.1021/acs.jpclett.9b0138410.1021/acs.jpclett.9b01384 ↗
45. 10.1021/acsami.2c1532710.1021/acsami.2c15327 ↗
46. 10.1002/anie.20210174410.1002/anie.202101744 ↗
47. 10.1016/j.ijbiomac.2025.14328610.1016/j.ijbiomac.2025.143286 ↗
48. 10.1021/acsami.4c0085310.1021/acsami.4c00853 ↗
49. 10.1039/C6CP02561G10.1039/C6CP02561G ↗
50. 10.1038/ncomms635710.1038/ncomms6357 ↗
51. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
52. 10.1002/anie.20200778610.1002/anie.202007786 ↗
53. 10.1039/D1NJ01272J10.1039/D1NJ01272J ↗
54. 10.1016/j.colsurfb.2020.11081010.1016/j.colsurfb.2020.110810 ↗
55. 10.1016/j.jhazmat.2019.12078210.1016/j.jhazmat.2019.120782 ↗
56. 10.1039/D0TB02360D10.1039/D0TB02360D ↗
57. 10.1016/j.envc.2022.10053410.1016/j.envc.2022.100534 ↗
58. 10.1016/j.jcis.2022.06.06910.1016/j.jcis.2022.06.069 ↗
59. 10.1016/j.biomaterials.2021.12111010.1016/j.biomaterials.2021.121110 ↗
60. 10.1016/j.cej.2022.13556710.1016/j.cej.2022.135567 ↗
61. 10.3109/1071576100370980210.3109/10715761003709802 ↗
62. 10.1016/j.actbio.2023.10.02410.1016/j.actbio.2023.10.024 ↗
63. 10.1002/1878-0261.1285110.1002/1878-0261.12851 ↗
64. 10.1016/j.cej.2023.14249510.1016/j.cej.2023.142495 ↗
65. 10.1021/acsanm.0c0160710.1021/acsanm.0c01607 ↗